Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001415889-16-005397
Filing Date
2016-03-30
Accepted
2016-03-30 17:39:18
Documents
84
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT innv_dec312015.htm 10-K 2164007
2 CODE OF ETHICS ex_141.htm EX-14.1 28559
3 SUBSIDIARIES OF THE REGISTRANT ex_211.htm EX-21.1 4454
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex_231.htm EX-23.1 3459
5 CERTIFICATION ex_232.htm EX-23.2 3144
6 CERTIFICATION ex_311.htm EX-31.1 10754
7 CERTIFICATION ex_312.htm EX-31.2 10685
8 CERTIFICATION ex_321.htm EX-32.1 10089
  Complete submission text file 0001415889-16-005397.txt   7146663

Data Files

Seq Description Document Type Size
9 innv-20151231.xml EX-101.INS 1119062
10 innv-20151231.xsd EX-101.SCH 85597
11 innv-20151231_cal.xml EX-101.CAL 62064
12 innv-20151231_def.xml EX-101.DEF 244588
13 innv-20151231_lab.xml EX-101.LAB 512989
14 innv-20151231_pre.xml EX-101.PRE 398465
Mailing Address 4275 EXECUTIVE SQUARE, SUITE 200 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE, SUITE 200 LA JOLLA CA 92037 858-964-5123
INNOVUS PHARMACEUTICALS, INC. (Filer) CIK: 0001411879 (see all company filings)

EIN.: 870324697 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52991 | Film No.: 161540998
SIC: 2834 Pharmaceutical Preparations